Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Acute effect of inhaled corticosteroid on exhaled breath temperature in asthmatic patients Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation Year: 2012
Endothelin -1 in exhaled breath condensate during omalizumab therapy in patients with severe persistent allergic asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Metabolomics applied to exhaled breath condensate in asthmatic children treated with inhaled steroids Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
Il-6 levels in exhaled breath condensate (EBC) of children with moderate well-controlled asthma stepping down inhaled corticosteroids Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017
Effects of inhaled corticosteroids on cough in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Effects of childhood asthma and inhaled corticosteroid treatment on EBC levels of IL-4 and TNF-α Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients Source: International Congress 2017 – Management of COPD Year: 2017
Influence of oral steroid use in difficult-to-control asthma patients on metabolomic profile of oxidative stress in exhaled breath condensate (EXAIR project) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 40s Year: 2001
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
Comparison of nasal steroids, antileukotrienes and combination therapy in seasonal allergic rhinitis: effect on exhaled breath markers Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
Profile of prostanoids in exhaled breath condensate in childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 400s Year: 2003
Effects of inhaled steroid therapy on exhaled breath condensate and blood biomarkers in newly diagnosed smoker asthmatics Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014
The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008
Leukotrienes in exhaled breath condensate in childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003